The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Shares of Vertex Pharmaceuticals Inc. VRTX slipped 1.72% to $416.96 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.21 ...

With Corbin Burnes, Blake Snell and Max Fried having already made their decisions in free agency, the top pitcher remaining on the market presents an unconventional case. Money won't play much of ...

Oh Iga, what have you done. (Photo by Hannah Peters/Getty Images) Swiatek however wasn’t alone in fuelling the long-running feud between the two states as Alex de Minaur refused to back in ...

Vertex Pharmaceuticals (NASDAQ: VRTX) is a biotechnology company with a strong track record of success in developing treatments for cystic fibrosis (CF). Vertex is strategically expanding into the ...

It usually doesn't matter if you buy a given stock immediately or two weeks later. Sure, the stock could move up or down but typically not enough to matter all that much. However, there are ...

The most recent trading session ended with Vertex Pharmaceuticals (VRTX) standing at $416.96, reflecting a -1.72% shift from the previouse trading day's closing. The stock's performance was behind ...

Alex Bregman's free-agent odyssey is now in its third month, with Spring Training fast approaching for a two-time All-Star presently without an MLB home. The wait for the former Houston Astros ...

which include Alex Bregman and Pete Alonso. For the most part, the latter has been heavily connected to a return to the Mets. Bregman's list of suitors is a bit of a mystery, and reportedly ...

Alex Bregman remains one of the biggest names still unsigned in free agency, despite a constant barrage of rumors about him. As of now and following a recent report from his agent, Scott Boras ...